Streetbeat News

Stock Prices

GWW

A significant bearish stance has been taken on W.W. Grainger (NYSE:GWW) as evidenced by unusual options activity. The sentiment among these big-money traders is 75% bearish and 25% bullish. The trades include 2 puts amounting to $59,860 and 10 calls amounting to $503,109. The targeted price range for W.W. Grainger over the last 3 months is from $710.0 to $750.0. The current price of GWW is $714.29.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 6:35 pm

INTU

A significant amount of unusual options activity has been detected for Intuit (NASDAQ:INTU), with a majority of investors taking a bearish stance. The trades range from $495.0 to $570.0 for Intuit over the last 3 months. The current price of INTU is $541.09, with RSI indicators suggesting a neutral position. Analysts from Wells Fargo, Wolfe Research, Piper Sandler, Mizuho, and HSBC have given varied ratings and price targets.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 6:34 pm

EL

A large bearish position has been taken on Estee Lauder Cos (NYSE:EL), with 80% of big-money traders showing bearish sentiment. The overall sentiment is split between 20% bullish and 80% bearish. The whales have been targeting a price range from $130.0 to $195.0 for Estee Lauder Cos over the last 3 months. JP Morgan, Redburn Atlantic, Citigroup, and Goldman Sachs have maintained their ratings on Estee Lauder Cos with price targets of $173, $150, $155, and $185 respectively.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 6:34 pm

JPM

SCHW

SPY

Social Security benefits will see a cost of living boost of 3.2% in 2024, raising the average monthly payment to $1,907. The adjustment is aimed at helping retirees cope with higher inflation. The SPDR S&P 500 ETF Trust (SPY) dipped after the Consumer Price Index (CPI) reading came in higher than expected. The cost of living adjustment could benefit brokerages like Charles Schwab Corporation (SCHW) and JPMorgan Chase & Co (JPM) as monthly contributions increase.

Portfolio Pulse from Aaron Bry

October 12, 2023 | 6:31 pm

ALHC

Stephens initiated coverage on Alignment Healthcare Inc (NASDAQ:ALHC) with an Equal Weight rating and a price target of $9. The analysts are looking for signs of the company's capacity to achieve sustainable Adjusted EBITDA profitability in 2024 and beyond. Despite significant capabilities and a notable enrollment growth rate, the company has not yet achieved its profitability goal. The Medicare Advantage market is expected to face a challenging reimbursement landscape in 2024.

Portfolio Pulse from Vandana Singh

October 12, 2023 | 6:31 pm

K

Barclays analyst Andrew Lazar maintains an Underweight rating on Kellanova (NYSE:K) and has lowered the price target from $69 to $57.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:29 pm

GOLD

A significant amount of unusual options activity has been observed for Barrick Gold (NYSE:GOLD), with a bearish stance being taken by a majority of investors. Of the 15 strange trades detected, 53% were bearish and 46% bullish. The total amount for the 3 puts was $124,308 and for the 12 calls was $648,000. Whales have been targeting a price range from $13.0 to $17.0 for Barrick Gold over the last 3 months. The price of GOLD is currently down -0.69% at $15.12. UBS, BMO Capital, and Jefferies have maintained their Buy, Outperform, and Hold ratings respectively.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 6:22 pm

CAT

A whale investor has taken a bearish stance on Caterpillar (NYSE:CAT), with 72% of the spotted trades being bearish. The trades include 6 puts amounting to $447,980 and 5 calls amounting to $338,960. The targeted price range for Caterpillar over the last 3 months is from $262.5 to $320.0. The current price of CAT is down -1.08% at $269.88, and RSI indicators suggest it may be approaching oversold. The next earnings are expected in 14 days.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 6:22 pm

MRNA

A significant bearish stance has been taken on Moderna (NASDAQ:MRNA) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split, with 40% bullish and 60% bearish. The whales have been targeting a price range from $79.0 to $150.0 for Moderna over the last 3 months. Argus Research maintains their Buy rating on Moderna, with a price target of $140.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 6:22 pm

JKHY

Goldman Sachs has downgraded Jack Henry & Associates from Neutral to Sell and set a price target of $140. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:17 pm